These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7093101)

  • 1. Labetalol in general practice: a review.
    Kane JA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):59S-63S. PubMed ID: 7093101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term study of labetalol in general practice.
    Kane J; Gregg I; Stephens MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):167S-170S. PubMed ID: 118766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
    Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of long-term treatment with labetalol.
    Waal-Manning HJ; Simpson FO
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):65S-73S. PubMed ID: 6980012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labetalol in essential hypertension.
    Breckenridge A; Orme M; Serlin MJ; Maciver M
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
    Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with labetalol in essential hypertension.
    Tuomilehto J; Nissinen A; Elo J
    Curr Med Res Opin; 1980; 6(6):407-15. PubMed ID: 7363641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
    Ferrari A; Buccino N; Di Rienzo M; Pedotti A; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S42-52. PubMed ID: 6169959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN; Bauer GE; Ross M; Larkin H
    Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.